Amb motiu del tancament d'estiu, la validació de documents es reprendrà a partir del 28 d'agost de 2026. Disculpeu les molèsties.
Con motivo del cierre de verano, la validación de documentos se reanudará a partir del 28 de agosto de 2026. Disculpad las molestias
Due to the summer closure, document validation will resume starting August 28, 2026. We apologize for any inconvenience.

Document type

Article

Version

Published version

Publication date

Publication license

cc-by-nc (c) Spinelli, Guglielmo et al., 2022
Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/192742

Nanotechnological approaches to address photosensitizers' limitations: towards improved clinical applicability of photodynamic therapy

Journal Title

Director/Tutor

Journal ISSN

Volume Title

Abstract

Photodynamic therapy (PDT) uses a combination of molecular oxygen, light and a photosensitizer (PS) to generate singlet oxygen or reactive oxygen species (ROS), which can eradicate tumoral cells. All currently approved PSs for cancer treatment are molecular PSs. To date, no nanoparticlebased PSs are used clinically although it has widely been shown that nanotechnology may help to improve the properties of molecular PSs; for instance, molecular PSs suffer from some intrinsic limitations that undermine their therapeutic efficacy. In the present minireview, the most critical weaknesses exhibited by molecular PSs are described, and the potential use of nanoparticles (NPs) to address them and to reach the clinics is discussed.

Subject (English)

Citation

Citation

SPINELLI, Guglielmo, CABALLERO HERNÁNDEZ, Ana Belén and GÁMEZ ENAMORADO, Patrick. Nanotechnological approaches to address photosensitizers' limitations: towards improved clinical applicability of photodynamic therapy. Chemistry Squared. 2022. Vol. 6, num. 2. ISSN 2604-0794. [consulted: 17 of August of 2026]. Available at: https://hdl.handle.net/2445/192742

Export metadata

JSON - METS

Share record